Pliant Therapeutics Inc (PLRX)

NASDAQ
Currency in USD
11.14
+0.22(+2.01%)
Closed
After Hours
11.28+0.14(+1.26%)
PLRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
10.6811.40
52 wk Range
10.2218.92
Key Statistics
Edit
Prev. Close
10.92
Open
10.74
Day's Range
10.68-11.4
52 wk Range
10.22-18.92
Volume
818.49K
Average Volume (3m)
511.49K
1-Year Change
-35.76%
Book Value / Share
5.69
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PLRX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
40.18
Upside
+260.70%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period
Show more

Pliant Company Profile

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company’s lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Employees
166

Compare PLRX to Peers and Sector

Metrics to compare
PLRX
Peers
Sector
Relationship
P/E Ratio
−3.4x−3.1x−0.6x
PEG Ratio
0.16−0.060.00
Price/Book
2.0x0.9x2.6x
Price / LTM Sales
-2.7x3.1x
Upside (Analyst Target)
259.1%122.6%53.1%
Fair Value Upside
Unlock26.5%7.5%Unlock

Analyst Ratings

13 Buy
0 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 40.18
(+260.70% Upside)

Earnings

Latest Release
Nov 08, 2024
EPS / Forecast
-0.95 / -0.97
Revenue / Forecast
-- / 472.22K
EPS Revisions
Last 90 days

FAQ

What Is the Pliant (PLRX) Stock Price Today?

The Pliant stock price today is 11.14.

What Stock Exchange Does Pliant Trade On?

Pliant is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Pliant?

The stock symbol for Pliant is "PLRX."

What Is the Pliant Market Cap?

As of today, Pliant market cap is 677.91M.

What is Pliant Earnings Per Share?

The Pliant EPS is -3.34.

What Is the Next Pliant Earnings Date?

Pliant will release its next earnings report on 03 Mar 2025.

From a Technical Analysis Perspective, Is PLRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.